Abstract:Newcastle disease (ND) and infectious bursal disease (IBD) are two viral infectious diseases that are extremely damaging to the poultry industry and are widespread throughout the world. It is necessary to develop a safe and effective vaccine against IBD and ND because vaccination is an effective preventive measure. It has been discovered that recombinant proteins expressed by an expression system in which a fragment of mammalian Immunoglobulin G (IgG) Fragment crystallizable (Fc) is linked to a segment of a gene have antibody-like properties that increase the exogenous protein's serum half-life. Heavy chain constant region 3 and heavy chain constant region 4 (CH3-CH4) of Avian Immunoglobulin Y (IgY) is structurally very similar to mammalian Ig G Fc. In this study, a bivalent vaccine rClone30-VP2L-CH3-CH4-GMCSF was developed by using NDV rClone30-chGM-CSF vector to produce VP2L-CH3-CH4 fusion protein. The vaccine has been given to 14-day-old specific pathogen free (SPF) free chickens to test whether it has the potential to prevent IBD and ND. Anti-IBDV and anti-NDV antibody levels in serum were evaluated using ELISA and HI, respectively, and the contents of CD4+ T, CD8+ T, and B cells in leukocytes were determined via flow cytometry. The contents and mRNA transcription levels of four inflammatory factors, IL-1β, IL-4, IFN-γ and chGM-CSF, were detected by ELISA and real-time PCR respectively. The results showed that after vaccination with the rClone30-VP2L-CH3-CH4-GMCSF vaccine, the levels of anti NDV and anti IBDV antibodies in chickens were significantly higher than those of the rClone30 vaccine and commercial vaccines. Meanwhile, the contents and transcription levels of inflammatory factors in chickens inoculated with rClone30-VP2L-CH3-CH4-GMCSF were significantly increased, and the proliferation response of B cells, CD4+ and CD8+ T cells was also stronger. However, the rClone30-VP2L-CH3-CH4-GMCSF vaccine had no significant advantage over the rClone30-VP2L-GMCSF vaccine in any of the above-mentioned features. In summary, rClone30-VP2L-CH3-CH4-GMCSF can stimulate the body to produce a stronger immune response, showing its potential to be considered as vaccine against IBD and ND, but the addition of CH3-CH4 did not improve the vaccine's immune effect as expected. The research lays the foundation for developing vaccines for other infectious viral diseases and avoids a unrealistic vaccine optimization method.

The Avian EB66(R) Cell Line, Application to Vaccines, and Therapeutic Protein Production

Experimental studies from shake flasks to 3 L stirred tank bioreactor of nutrients and oxygen supply conditions to improve the growth of the avian cell line DuckCelt®-T17

Development, Characterization and Optimization of a New Suspension Chicken-Induced Pluripotent Cell Line for the Production of Newcastle Disease Vaccine.

Construction of a Peacock Immortalized Fibroblast Cell Line for Avian Virus Production.

Induced Multilineage Differentiation of Chicken Embryonic Germ Cells Via Embryoid Body Formation

Development and evaluation of a chicken embryo fibroblast cell culture based live attenuated Indian strain duck plague vaccine

Df-1 Cell Adaptation and Immune Responses of Lc-75 Vaccinal Strain of Infectious Bursal Disease Virus in Chicken

Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain

Duckweeds as edible vaccines in the animal farming industry

CHO cells for virus-like particle and subunit vaccine manufacturing

[The Potential of Avian Cytokines As Immunotherapeutics and Vaccine Adjuvants].

Optimization of process parameters for specific pathogen-free chicken embryonic fibroblast cultivation for yellow fever vaccine production

Derivation and Characteristics of Pluripotent Embryonic Germ Cells in Duck.

Development and Evaluation of a Bivalent Vaccine Based on Recombinant Newcastle Disease Virus Expressing Infectious Bursal Disease Virus VP2L-CH3-CH4 in SPF Chickens

Development and Evaluation of the Biological Adjuvant Bivalent Vaccine for Preventing Newcastle Disease and Infectious Bursal Disease

The Establishment and Characteristics of Cell-Adapted IBV Strain H120.

Highly Efficient Production of an Influenza H9N2 Vaccine Using MDCK Suspension Cells

Recombinant Avian β-Defensin Produced by Food-Grade Lactococcus as a Novel and Potent Immunological Enhancer Adjuvant for Avian Vaccine

In ovo applications in poultry: A review,

A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis

Avian Cell Culture Models to Study Immunomodulatory Properties of Bioactive Products